TFF1 is differentially expressed in stationary and migratory rat gastric epithelial cells (RGM-1) after in vitro wounding: Influence of TFF1 RNA Interference on cell migration

Cellular Physiology and Biochemistry

Volumn 32, Issue 4, 2013, Pages 997-1010

  Fu, Ting ^a   Kalbacher, Hubert ^b   Hoffmann, Werner ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cell migration; EMT; Gastrokine 2; LGR5; Mucosal injury; Restitution; siRNA; Survivin; TFF1; Trefoil factor; Wound healing

Indexed keywords

BETA ACTIN; CYCLIN A2; PEPSINOGEN II; PROTEIN; SMOOTH MUSCLE ACTIN; STROMAL CELL DERIVED FACTOR 1; SURVIVIN; TFF1 PROTEIN; UNCLASSIFIED DRUG; VIMENTIN; CELL MARKER; INTESTINAL TREFOIL FACTOR; SMALL INTERFERING RNA; TREFOIL FACTOR FAMILY PEPTIDE 1;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENETIC TRANSFECTION; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SECRETORY GRANULE; STOMACH EPITHELIUM; UPREGULATION; WESTERN BLOTTING; WOUND; CELL SEPARATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TARGETING; MUCOUS CELL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; STOMACH INJURY;

LOTUS; RATTUS;

ANIMALS; CELL LINE; CELL MOVEMENT; EPITHELIAL CELLS; GASTRIC MUCOSA; IMMUNOHISTOCHEMISTRY; PEPTIDES; RATS; WOUND HEALING;

EID: 84885062559     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000354501     Document Type: Article

References (73)

1. Ribieras S, Tomasetto C, Rio MC: The pS2/TFF1 trefoil factor, from basic research to clinical applications. Biochim Biophys Acta 1998;1378:F61-F77 (Pubitemid 28381126)
2. Tomasetto C, Rio MC: Pleiotropic effects of trefoil factor 1 deficiency. Cell Mol Life Sci 2005;62:2916-2920 (Pubitemid 43004744)
3. Kjellev S: The trefoil factor family -small peptides with multiple functionalities. Cell Mol Life Sci 2009;66:1350-1369
4. Hoffmann W: TFF peptides; in Kastin AJ (ed): Handbook of biologically active peptides (2nd edition). San Diego, Elsevier, 2013, pp1338-1345
5. Rio MC, Bellocq JP, Daniel JY, Tomasetto C, Lathe R, Chenard MP, Batzenschlager A, Chambon P: Breast cancer-Associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 1988;241:705-708
6. Hanby AM, Poulsom R, Singh S, Elia G, Jeffery RE, Wright NA: Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology 1993;105:1110-1116 (Pubitemid 23281500)
7. Westley BR, Griffin SM, May FE: Interaction between TFF1, a gastric tumor suppressor trefoil protein, and TFIZ1, a brichos domain-containing protein with homology to SP-C. Biochemistry 2005;44:7967-7975 (Pubitemid 40776657)
8. Kouznetsova I, Laubinger W, Kalbacher H, Kalinski T, Meyer F, Roessner A, Hoffmann W: Biosynthesis of gastrokine-2 in the human gastric mucosa: restricted spatial expression along the antral gland axis and differential interaction with TFF1, TFF2 and mucins. Cell Physiol Biochem 2007;20:899-908 (Pubitemid 350059733)
9. Chadwick M.P, Westley BR, May FE: Homodimerization and hetero-oligomerization of the single-domain trefoil protein pNR-2/pS2 through cysteine 58. Biochem J 1997;327:117-123 (Pubitemid 27455468)
10. Newton JL, Allen A, Westley BR, May FE: The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach. Gut 2000;46:312-320 (Pubitemid 30313380)
11. Kannan R, Tomasetto C, Staub A, Bossenmeyer-Pourie C, Thim L, Nielsen PF, Rio M: Human pS2/trefoil factor 1: production and characterization in Pichia pastoris. Protein Expr Purif 2001;21:92-98 (Pubitemid 32614501)
12. Chadwick MP, May FE, Westley BR: Production and comparison of mature single-domain 'trefoil' peptides pNR-2/pS2 Cys58 and pNR-2/pS2 Ser58. Biochem J 1995;308:1001-1007
13. Williams MA, Westley BR, May FE, Feeney J: The solution structure of the disulphide-linked homodimer of the human trefoil protein TFF1. FEBS Lett 2001;493:70-74 (Pubitemid 32245779)
14. Marchbank T, Westley BR, May FE, Calnan DP, Playford RJ: Dimerization of human pS2 (TFF1) plays a key role in its protective/healing effects. J Pathol 1998;185:153-158 (Pubitemid 28270927)
15. Prest SJ, May FE, Westley BR: The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells. FASEB J 2002;16:592-594
16. Bossenmeyer-Pourie C, Kannan R, Ribieras S, Wendling C, Stoll I, Thim L, Tomasetto C, Rio MC: The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis. J Cell Biol 2002;157:761-770 (Pubitemid 34847814)
17. Weise A, Dunker N: High trefoil factor 1 (TFF1) expression in human retinoblastoma cells correlates with low growth kinetics, increased cyclin-dependent kinase (CDK) inhibitor levels and a selective down-regulation of CDK6. Histochem Cell Biol 2013;139:323-338
18. Rodrigues S, Van Aken E, Van Bocxlaer S, Attoub S, Nguyen QD, Bruyneel E, Westley BR, May FEB, Thim L, Mareel M, Gespach C, Emami S: Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling. FASEB J 2003;17:7-16 (Pubitemid 36119830)
19. Williams R, Stamp GW, Gilbert C, Pignatelli M, Lalani EN: pS2 transfection of murine adenocarcinoma cell line 410.4 enhances dispersed growth pattern in a 3-D collagen gel. J Cell Sci 1996;109:63-71 (Pubitemid 26037928)
20. Emami S, Le Floch N, Bruyneel E, Thim L, May F, Westley B, Rio MC, Mareel M, Gespach C: Induction of scattering and cellular invasion by trefoil peptides in src-and RhoA-transformed kidney and colonic epithelial cells. FASEB J 2001;15:351-361 (Pubitemid 32141427)
21. Buache E, Etique N, Alpy F, Stoll I, Muckensturm M, Reina-San-Martin B, Chenard MP, Tomasetto C, Rio MC: Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice. Oncogene 2011;30:3261-3273
22. Rodrigues S, Rodrigue CM, Attoub S, Flejou JF, Bruyneel E, Bracke M, Emami S, Gespach C: Induction of the adenoma-carcinoma progression and Cdc25A-B phosphatases by the trefoil factor TFF1 in human colon epithelial cells. Oncogene 2006;25:6628-6636 (Pubitemid 44646190)
23. Emami S, Rodrigues S, Rodrigue CM, Le Floch N, Rivat C, Attoub S, Bruyneel E, Gespach C: Trefoil factor family (TFF) peptides and cancer progression. Peptides 2004;25:885-898 (Pubitemid 38721356)
24. Perry JK, Kannan N, Grandison PM, Mitchell MD, Lobie PE: Are trefoil factors oncogenic? Trends Endocrin Metab 2008;19:74-81 (Pubitemid 351317894)
25. Lefebvre O, Chenard MP, Masson R, Linares J, Dierich A, LeMeur M, Wendling C, Tomasetto C, Chambon P, Rio MC: Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996;274:259-262 (Pubitemid 26353205)
26. Soutto M, Belkhiri A, Piazuelo MB, Schneider BG, Peng D, Jiang A, Washington MK, Kokoye Y, Crowe SE, Zaika A, Correa P, Peek RM Jr, El-Rifai W: Loss of TFF1 is associated with activation of NF-?B-mediated inflammation and gastric neoplasia in mice and humans. J Clin Invest 2011;121:1753-1767
27. Saukkonen K, Tomasetto C, Narko K, Rio MC, Ristimaki A: Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice. Cancer Res 2003;63:3032-3036 (Pubitemid 36735846)
28. Karam SM, Tomasetto C, Rio MC: Trefoil factor 1 is required for the commitment programme of mouse oxyntic epithelial progenitors. Gut 2004;53:1408-1415 (Pubitemid 39265257)
29. Karam SM, Tomasetto C, Rio MC: Amplification and invasiveness of epithelial progenitors during gastric carcinogenesis in trefoil factor 1 knockout mice. Cell Prolif 2008;41:923-935
30. Hoffmann W: TFF (trefoil factor family) peptides and their potential roles for differentiation processes during airway remodeling. Curr Med Chem 2007;14:2716-2719 (Pubitemid 350048325)
31. Torres LF, Karam SM, Wendling C, Chenard MP, Kershenobich D, Tomasetto C, Rio MC: Trefoil factor 1 (TFF1/pS2) deficiency activates the unfolded protein response. Mol Med 2002;8:273-282
32. Playford RJ, Marchbank T, Goodlad RA, Chinery RA, Poulsom R, Hanby AM: Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci USA 1996;93:2137-2142 (Pubitemid 26079894)
33. Vandenbroucke K, Hans W, Van Huysse J, Neirynck S, Demetter P, Remaut E, Rottiers P, Steidler L: Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology 2004;127:502-513 (Pubitemid 39091899)
34. Katoh M: Trefoil factors and human gastric cancer (review). Int J Mol Med 2003;12:3-9
35. Rio MC, Chenard MP, Wolf C, Marcellin L, Tomasetto C, Lathe R, Bellocq JP, Chambon P: Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology 1991;100:375-379
36. Wright NA, Poulsom R, Stamp G, Van Noorden S, Sarraf C, Elia G, Ahnen D, Jeffery R, Longcroft J, Pike C: Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993;104:12-20 (Pubitemid 23040001)
37. Hoffmann W: Stem cells, self-renewal and cancer of the gastric epithelium. Curr Med Chem 2012;19:5975-5983
38. Hoffmann W: Self-renewal of the gastric epithelium from stem and progenitor cells. Front Biosci (Scholar) 2013;S5:720-731
39. Silen W, Ito S: Mechanisms for rapid re-epithelialization of the gastric mucosal surface. Annu Rev Physiol 1985;47:217-229 (Pubitemid 15142379)
40. Lacy ER: Rapid epithelial restitution in the stomach: an updated perspective. Scand J Gastroenterol 1995;30 Suppl 210:6-8
41. Wallace JL, Granger DN: The cellular and molecular basis of gastric mucosal defense. FASEB J 1996;10:731-740 (Pubitemid 26172819)
42. Jones MK, Tomikawa M, Mohajer B, Tarnawski AS: Gastrointestinal mucosal regeneration: role of growth factors. Front Biosci 1999;4:D303-309
43. Cheng AM, Morrison SW, Yang DX, Hagen SJ: Energy dependence of restitution in the gastric mucosa. Am J Physiol 2001;281:C430-C438
44. Hoffmann W: Trefoil factors TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution. Cell Mol Life Sci 2005;62:2932-2938 (Pubitemid 43004746)
45. Kobayashi I, Kawano S, Tsuji S, Matsui H, Nakama A, Sawaoka H, Masuda E, Takei Y, Nagano K, Fusamoto H, Ohno T, Fukutomi H, Kamada T: RGM1, a cell line derived from normal gastric mucosa of rat. In Vitro Cell Dev Biol-Animal 1996;32:259-261
46. Nakamura E, Takahashi S, Matsui H, Okabe S: Interleukin-1 beta inhibits growth factor-stimulated restoration of wounded rat gastric epithelial cell monolayers. Digest Dis Sci 1998;43:476-484 (Pubitemid 28155566)
47. Osada T, Watanabe S, Tanaka H, Hirose M, Miyazaki A, Sato N: Effect of mechanical strain on gastric cellular migration and proliferation during mucosal healing: role of Rho dependent and Rac dependent cytoskeletal reorganisation. Gut 1999;45:508-515 (Pubitemid 29447817)
48. Ragasa R, Nakamura E, Marrone L, Yanaka S, Hayashi S, Takeuchi K, Hagen SJ: Isothiocyanate inhibits restitution and wound repair after injury in the stomach: Ex vivo and in vitro studies. J Pharmacol Exp Therap 2007;323:1-9 (Pubitemid 47443255)
49. Znalesniak EB, Drer U, Hoffmann W: Expression profiling of stationary and migratory intestinal epithelial cells after in vitro wounding: restitution is accompanied by cell differentiation. Cell Physiol Biochem 2009;24:125-132
50. Wiede A, Jagla W, Welte T, Khnlein T, Busk H, Hoffmann W: Localization of TFF3, a new mucus-Associated peptide of the human respiratory tract. Am J Respir Crit Care Med 1999;159:1330-1335 (Pubitemid 29202575)
51. Carstea ED, Hough S, Wiederholt K, Welch PJ: State-of-the-Art modified RNAi compounds for therapeutics. IDrugs 2005;8:642-647 (Pubitemid 41093867)
52. Drer U, Hartig R, Bang S, Thim L, Hoffmann W: TFF3 and EGF induce different migration patterns of intestinal epithelial cells in vitro and trigger increased internalization of E-cadherin. Cell Physiol Biochem 2007;20:329-346 (Pubitemid 47340596)
53. Agace WW, Amara A, Roberts A.I, Pablos JL, Thelen S, Uguccioni M, Li XY, Marsal J, Arenzana-Seisdedos F, Delaunay T, Ebert EC, Moser B, Parker CM: Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation. Curr Biol 2000;10:325-328 (Pubitemid 30186136)
54. Smith JM, Johanesen PA, Wendt MK, Binion DG, Dwinell MB: CXCL12 activation of CXCR4 regulates mucosal host defense through stimulation of epithelial cell migration and promotion of intestinal barrier integrity. Am J Physiol 2005;288:G316-G326 (Pubitemid 40129584)
55. Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH, Sato T, Stange DE, Begthel H, van den Born M, Danenberg E, van den Brink S, Korving J, Abo A, Peters PJ, Wright N, Poulsom R, Clevers H: Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 2010;6:25-36
56. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-715 (Pubitemid 351636299)
57. Kalluri R, Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-1428
58. Bendris N, Arsic N, Lemmers B, Blanchard JM: Cyclin A2, Rho GTPases and EMT. Small GTPases 2012;3:225-228
59. Comamala M, Pinard M, Theriault C, Matte I, Albert A, Boivin M, Beaudin J, Piche A, Rancourt C: Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells. Brit J Cancer 2011;104:989-999
60. Znalesniak EB, Hoffmann W: Modulation of cell-cell contacts during intestinal restitution in vitro and effects of epidermal growth factor (EGF). Cell Physiol Biochem 2010;25:533-542
61. Arsic N, Bendris N, Peter M, Begon-Pescia C, Rebouissou C, Gadea G, Bouquier N, Bibeau F, Lemmers B, Blanchard JM: A novel function for cyclin A2: control of cell invasion via RhoA signaling. J Cell Biol 2012;196:147-162
62. Watanabe S, Hirose M, Yasuda T, Miyazaki A, Sato N: Role of actin and calmodulin in migration and proliferation of rabbit gastric mucosal cells in culture. J Gastroenterol Hepatol 1994;9:325-333 (Pubitemid 24227904)
63. Zahm JM, Kaplan H, Herard AL, Doriot F, Pierrot D, Somelette P, Puchelle E: Cell migration and proliferation during the in vitro wound repair of the respiratory epithelium. Cell Motil Cytoskel 1997;37:33-43 (Pubitemid 27199682)
64. Chiou SK, Moon WS, Jones MK, Tarnawski AS: Survivin expression in the stomach: implications for mucosal integrity and protection. Biochem Biophys Res Commun 2003;305:374-379 (Pubitemid 36555479)
65. Kaeffer B: Survival of exfoliated epithelial cells: a delicate balance between anoikis and apoptosis. J Biomed Biotechnol 2011;2011:534139
66. Chiou SK, Tanigawa T, Akahoshi T, Abdelkarim B, Jones MK, Tarnawski A.S: Survivin: A novel target for indomethacin-induced gastric injury. Gastroenterology 2005;128:63-73 (Pubitemid 40039959)
67. Mckenzie JA, Grossman D: Role of the apoptotic and mitotic regulator survivin in melanoma. Anticancer Res 2012;32:397-404
68. Waligorska-Stachura J, Jankowska A, Wasko R, Liebert W, Biczysko M, Czarnywojtek A, Baszko-Blaszyk D, Shimek V, Ruchala M: Survivin -prognostic tumor biomarker in human neoplasms -review. Ginekol Pol 2012;83:537-540
69. Cho SY, Klemke RL: Extracellular-regulated kinase activation and CAS/Crk coupling regulate cell migration and suppress apoptosis during invasion of the extracellular matrix. J Cell Biol 2000;149:223-236 (Pubitemid 30196711)
70. Kouznetsova I, Kalinski T, Meyer F, Hoffmann W: Self-renewal of the human gastric epithelium: new insights from expression profiling using laser microdissection. Mol Biosyst 2011;7:1105-1112
71. Kouznetsova I, Peitz U, Vieth M, Meyer F, Vestergaard EM, Malfertheiner P, Roessner A, Lippert H, Hoffmann W: A gradient of TFF3 (trefoil factor family 3) peptide synthesis within the normal human gastric mucosa. Cell Tissue Res 2004;316:155-165 (Pubitemid 38658536)
72. Kouznetsova I, Kalinski T, Peitz U, Mnkemller KE, Kalbacher H, Vieth M, Meyer F, Roessner A, Malfertheiner P, Lippert H, Hoffmann W: Localization of TFF3 peptide in human esophageal submucosal glands and gastric cardia: differentiation of two types of gastric pit cells along the rostro-caudal axis. Cell Tissue Res 2007;328:365-374 (Pubitemid 46452198)
73. Albert TK, Laubinger W, Mller St, Hanisch F-G, Kalinski T, Meyer F, Hoffmann W: Human intestinal TFF3 forms disulfide-linked heteromers with the mucus-Associated FCGBP protein and is released by hydrogen sulphide. J Proteome Res 2010;9:3108-3117.